<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04424329</url>
  </required_header>
  <id_info>
    <org_study_id>19.17.NRC</org_study_id>
    <nct_id>NCT04424329</nct_id>
  </id_info>
  <brief_title>Effect of a Specific Blend of Fibers and Probiotics on the Microbiome</brief_title>
  <official_title>Effect of a Specific Blend of Fibers and Probiotics on the Microbiome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate the effect of a mix of fibers and probiotics on faecal microbiota
      challenged by an environmental stress
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2, 2020</start_date>
  <completion_date type="Anticipated">July 3, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimizing microbiota composition change</measure>
    <time_frame>Daily from Day -4 to day + 7 (Day 0 is the start of the challenge)</time_frame>
    <description>Shotgum metagenomics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increased intestinal microbiota diversity</measure>
    <time_frame>Daily from Day -4 to day + 7 (Day 0 is the start of the dietary challenge)</time_frame>
    <description>Measured by the Shannon diversity index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increased microbiota gene richness</measure>
    <time_frame>Daily from Day -4 to day + 7 (Day 0 is the start of the dietary challenge)</time_frame>
    <description>Measured by gene counts from metagenome sequencing of the fecal microbiota</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut comfort</measure>
    <time_frame>Daily from Day -10 to day + 7 (Day 0 is the start of the dietary challenge)</time_frame>
    <description>Assessed each Gastrointestinal Symptoms (VOMITING, NAUSEA, AUDIBLE BOWEL SOUNDS, FLATULENCE, ABDOMINAL CRAMPS, BLOATING ) with a scale (from 0 to 10, 10 being the worst outcome)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Microbiota Perturbation by an Environmental Challenge</condition>
  <arm_group>
    <arm_group_label>Nutrition intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of fibers and probiotics daily for 22 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fibers and probiotics</intervention_name>
    <description>A blend of fibers and seven probiotics</description>
    <arm_group_label>Nutrition intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Informed consent signed

          2. Adult men and women aged 18 to 45 years

          3. Healthy based on the medical screening visit and medical questionnaire

          4. BMI in the range of 18.5 to 29.9 kg/m2.

        Exclusion Criteria:

          1. Known food allergy and intolerance

          2. Currently participating in another clinical trial or research project

          3. Fewer than 5 spontaneous bowel movements per week on average

          4. Chronic or recurrent diarrhea with spontaneous bowel movements more often than 2 times
             daily

          5. Systemic antibacterial/antifungal therapy during the 3 months prior to study enrolment

          6. Medications or supplements that are known to alter gut function or microflora during
             the 4 weeks prior to study enrolment

          7. Volunteers under anti-hyperlipidemic, antihypertensive, estrogen-related and/or
             anticoagulant agents

          8. Prior gastrointestinal surgery (apart from appendectomy, cholecystectomy or
             herniotomy)

          9. Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols,
             1 dl of red or white wine, or 3 dl of beer.

         10. Artificially sweetened beverage intake higher than 1000 ml/ per day

         11. Female subjects will be excluded if they are pregnant, gave birth in the last 6
             months, or are lactating.

         12. Subject having a hierarchical or family link with the research team members.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sami Damak</last_name>
    <role>Principal Investigator</role>
    <affiliation>Société des produits Nestlé</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sami Damak, M.D. Ph.D</last_name>
    <phone>41 21 785 8712</phone>
    <email>sami.damak@rdls.nestle.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Société des produits Nestlé/Metabolic Unit</name>
      <address>
        <city>Lausanne</city>
        <zip>1000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Piccardi</last_name>
      <phone>41 21 785 9510</phone>
      <email>nathalie.piccardi@rdls.nestle.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 8, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

